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ABSTRACT 
 
        The nasal carriage of staphylococci in diseased and healthy 
individuals was studied. The sensitivity of isolates to different 
antibacterial agents was determined to express the effect of 
hospitalization in acquiring drug resistance. Sixty nasal swabs were 
collected, 50 samples from patients (spent different periods in the 
hospital) and 10 samples from healthy individuals.  
        Isolation was achieved on Baird-Parker medium. The isolated 
staphylococci from patients included Staph. aureus (20, 33.3%), Staph. 
auricularis (2, 3.3%), Staph. caprae (1, 1.7%), Staph. caseolyticus (4, 
6.7%), Staph. chromogens (10, 16.7%), Staph. epidermidis (5, 8.3%), 
Staph. gallinarium (1, 1.7%), Staph. haemolyticus (3, 5%), Staph.hyicus 
(5, 8.3%), Staph. kloosii (2, 3.3%), Staph. lentus (2, 3.3%), Staph. 
lugdunensis (1, 1.7%), Staph. sciuri (2, 3.3%), Staph. saprophyticus (1, 
1.7%), Staph. schleiferi  (1, 1.7%). The isolated staphylococci from 
healthy individuals included Staph aureus (3, 30%), Staph. epidermidis 
(3, 30%), Staph .hyicus (1, 10%), Staph. intermiduis (2, 20%), Staph. 
lugdunensis (1, 10%). 
            The antibiotic sensitivity patterns of isolates recovered from 
patients showed the gradual development of resistance as the patients 
spent more time in the hospital. Staphylococci isolated from normal 
individuals showed lower degree of resistance to the tested antibacterial 
agents. 
 It was concluded that many staphylococci including S. aureus 
colonize the nasal cavity of patients and begin to acquire resistance 
against different antibacterial agents with time in the hospital. 
IX 
 ﺧﻼﺻﺔ اﻻﻃﺮوﺣﺔ
 
          أﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﻤﻌﺮﻓﺔ إﻧﺘﺸﺎر أﻧﻮاع ﺑﻜﺘﺮﻳﺎ اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺘﻰ ﺗﻮﺟﺪ ﻓﻰ 
ﻣﻜﺜﻮا ﻓﺘﺮات ﻣﺨﺘﻠﻔﺔ  ) ﻣﻦ اﻟﻤﺮﺿﻰ واﻷﺻﺤﺎء ﺣﻴﺚ ﺗﻢ ﺟﻤﻊ ﺧﻤﺴﻴﻦ ﻣﺴﺤﺔ أﻧﻮف اﻟﻤﺮﺿﻰ
  . وﻋﺸﺮة ﻣﺴﺤﺎت  ﻣﻦ اﻓﺮاد أﺻﺤﺎء (داﺧﻞ اﻟﻤﺴﺘﺸﻔﻰ
ﻰ اﻧﻮاع اﻟﺒﻜﺘﻴﺮﻳﺎ اﻟﺘﻰ ﻋﺰﻟﺖ وذﻟﻚ ﺑﻐﺮض ﻣﻌﺮﻓﺔ اﻻﺛﺮ اﻟﺬى            أﺟﺮى اﺧﺘﺒﺎر اﻟﺤﺴﺎﺳﻴﺔ ﻋﻠ
ﻳﺤﺪﺛﻪ زﻣﻦ  ﺑﻘﺎء اﻟﻤﺮﻳﺾ داﺧﻞ اﻟﻤﺴﺘﺸﻔﻰ ﻋﻠﻰ اآﺘﺴﺎب اﻟﺒﻜﺘﻴﺮﻳﺎ اﻟﻤﻌﺰوﻟﺔ ﻣﻨﻪ ﻟﻠﻤﻘﺎوﻣﺔ ﺿﺪ 
  . اﻟﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ
 ﺑﺎرآﺮ ﺣﻴﺚ   ﺗﻀﻤﻨﺖ أﻧﻮاع اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻤﻌﺰوﻟﺔ ﻣﻦ -    ﺗﻢ اﻟﻌﺰل ﺑﺎﺳﺘﺨﺪام وﺳﻂ ﺑﻴﺮد
  :    ﺿﻰ آﻞ ﻣﻦاﻷﻓﺮاد اﻟﻤﺮ
اﻟﻤﻜﻮرات , (3.3)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻷذﻧﻴﺔ , (3.33)% اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺬهﺒﻴﺔ 
 اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ , (7.6)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻤﺘﺠﺒﻨﺔ ,  (7.1)%اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻤﻌﺰﻳﺔ 
ﻟﺤﻤﺎﺋﻤﻴﺔ اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ ا,(3.8)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺒﺸﺮاوﻳﺔ , (7.61)%ﺔ ﻴاﻟﺼﺒﻐ
, (3.8)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺨﻨﺰﻳﺮﻳﺔ ,(5)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ ﺣﺎﻟﺔ اﻟﺪم , (7.1)%
اﻟﻤﻜﻮرات , (3.3)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻌﺪﺳﻴﺔ , (3.3)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻜﻠﻮﺳﻴﺔ 
اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ , (3.3)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺴﻨﺠﺎﺑﻴﺔ , (7.1)%اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻠﻘﺪوﻧﻴﻨﺴﻴﺔ 
  (.                          7.1)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺸﻠﻴﻔﺮﻳﺔ , (7.1)%ﺔ ﻟﺮﻣﻴا
اﻟﻤﻜﻮرات , (03)% اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺬهﺒﻴﺔ ﻓﻰ اﻷﻓﺮاد اﻷﺻﺤﺎء ﻓﺘﻀﻤﻨﺖ آﻞ ﻣﻦ     أﻣﺎ
اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ ,(01)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺨﻨﺰﻳﺮﻳﺔ ,( 03)%اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺒﺸﺮاوﻳﺔ 
  (.01)%اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻠﻘﺪوﻧﻴﻨﺴﻴﺔ , (02)%اﻟﻮﺳﻄﻴﺔ 
 ﺑﻌﺪ إﺟﺮاء إﺧﺘﺒﺎر اﻟﺤﺴﺎﺳﻴﺔ وﺟﺪ أن هﻨﺎﻟﻚ ازدﻳﺎد ﻓﻰ ﻣﻘﺎوﻣﺔ اﻻﻧﻮاع اﻟﺘﻰ ﻋﺰﻟﺖ ﻣﻦ اﻟﻤﺮﺿﻰ
  . وان هﺬﻩ اﻟﻤﻘﺎوﻣﺔ ﺗﺰداد ﺗﺒﻌﺎ ﻻزدﻳﺎد ﻣﺪة اﻟﺒﻘﺎء ﺑﺎﻟﻤﺴﺘﺸﻔﻰﻟﻌﺪد ﻣﻦ ﻣﻀﺎدات اﻟﺠﺮاﺛﻴﻢ 
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INTRODUCTION 
 
           The environment around us is full of many different 
organisms, some of them are pathogenic, where as other are natural 
inhabitants and are non-pathogenic which under suitable conditions they 
become pathogenic for human and animals. The environmental factors 
have a prominent role in growth or death of organisms and on their 
success to cause diseases depending on the availability of suitable 
conditions for growth. 
Staphylococci have been considered as one of the important 
bacteria that affect man and animals. They are also accepted as part of the 
normal bacterial flora and one of the main causes of food-poisoning in 
man in many places. They are disseminated in pus and dried exudates of 
infected wounds and they rapidly develop resistance to many 
antimicrobial agents and present difficult therapeutic problems, they are 
also resistant to heat and salt (Jawetz et al., 1990).  
The nasal carriage of Staph. aureus was widespread and  of  
considerable epidemiological significance. As shown by Cruickshank 
(1953), Weinstein (1959), Williams (1956) and Daniel (1977), carriers 
were more prone to skin sepsis and postoperative infection caused by 
Staphylococcus aureus than are non-carriers. Carriage rates in various 
populations were investigated extensively, but most of the work in this 
field was done with population living in temperate environments. There 
was little information about carriage-rates in the tropics, although the 
study by Paul et al. (1982) in Nigerian hospital gave results in broad 
agreement with the work done in countries with a temperate climate. 
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The importance of the present research lied behind the fact that 
staphylococci may result in life-threatening infections especially those 
which are resistant to different antibacterials. They may also represent 
reservoir of resistant factors to other pathogens. Accordingly the present 
study was carried out in Khartoum state, Sudan to: 
1- Detect different Staphylococcus species in the nasal cavity of healthy 
and diseased individuals. 
2- To study the role of residence time of patients in the hospital in 
acquiring of isolates to antibiotic resistance.  
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CHAPTER ONE 
LITREATURE REVIEW 
 
1.1. Nosocomial infection: 
The word nosocomial is made up of two Greek words, nosus means 
disease and komeion means to take care of. Nosocomial infection could 
therefore refer to any diffiction acquired by a patient while under medical 
supervision, but it now refers more narrowly to a hospital-acquired 
infection. 
Most nosocomial infections are due to bacteria. Since antibiotics 
are frequently used within hospitals, the types of bacteria isolated from 
this environment are more likely to develop resistance to antibiotics than 
bacteria outside of the hospital. Accordingly nosocomial infections due to 
bacteria could be serious and difficult to treat. 
Staphylococcus aureus grows harmlessly on the skin and mucous 
membranes especially of the upper respiratory and digestive tracts (Carter 
and Wise, 2004). It spreads from these sites into the environment by the 
hand, handkerchiefs, clothing, and dust consisting of skin squamas and 
cloth fibres (Baird et al., 1996). It causes infection usually when the skin 
is wounded. 
In 1950th and 1960th, many studies have shown that chronic or 
recurrent staphylococcal infections could be associated with nasal 
carriage of staphylococci (Tulloch, 1954; Solberg, 1965; White, 1963; 
Weinstein, 1959; Nahmias and shulam, 1972).  
1.2. Bacterial aetiology of nosocomial infection: 
Nosocomial infections are primarily caused by Enterococcus 
species, Escherichia coli, Pseudomonas species, Staphylococcus species 
(Black, 1996; Torto, Funk and Case, 1995). 
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1.3. Mode of transmission: 
Transmission from the above mentioned sites, into the environment 
occurs by hands, handkerchiefs, clothes and dust consisting of the skin 
squamas and cloth fibres. It may spread from babies to nursing mothers, 
who then develop mammitis. During the first days of life most babies 
become colonized by staphylococci acquired from their mothers, nurses 
or environment. In babies born in hospitals, the nose, umbilical stump and 
moist areas of the skin are commonly colonized by Staph. aureus. Nasal 
carriage in babies, as well as in adults, is usually long-lasting (Arbuthnott, 
1992). 
 Cross-infection is an important method of spreading of 
staphylococcal diseases, particularly in closed communities such as 
hospitals. Direct contact is probably the most important mode of transfer, 
but air-born dust and air-born droplet nuclei may also be involved. 
Domesticated and some wild animals may disseminate Staph. aureus 
from infected lesions or carriage site and thus cause infection in man, e.g. 
a dairy cow with staphylococcal infection of the udder may give infected 
milk which can cause staphylococcal food poisoning (Arbuthnott,1992).  
1.4. Prevention of nosocomial infection: 
Methods of prevention of nosocomial infection and breaking the 
chain of transmission include (Black, 1996; Torto, Funk and Case, 1995): 
- Observance of aseptic technique. 
- Frequent hand washing especially between patients. 
- Careful handling, cleaning, and disinfection of fomites. 
- Where possible use of single-use disposable items. 
Various institutional methods such as air filtration within the hospital 
should be used.  
1.5. Staphylococci:  
Staphylococci are Gram-positive cocci that tend to arrange in 
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irregular clusters or bunches of grapes. The average diameter of cocci is 
1.0 µm. They are facultative anaerobes (fermentative), catalase positive, 
oxidase negative and non-motile. They grow readily on a variety of media 
and are metabolically active, fermenting many carbohydrates and 
producing pigments that vary from white to deep yellow. Pathogenic 
staphylococci often hemolyse blood and coagulase plasma (Quin et al., 
1999). 
Some staphylococci are members of the normal flora of various 
organs in the body. Staphylococci rapidly develop resistant to many anti-
microbial agents (Jawetz, Melinck and Adelberg’s, 2001). 
1.5.1. History of staphylococci: 
         Alexander Ogeston was the first to describe staphylococci in human 
pus in 1878. Tow years later, Pasteur cultivated the organisms in liquid 
medium, and in the following year Ogeston showed it to be pathogenic 
for mice and guinea pigs. In 1884 Rosenbach described the two species, 
Staph. aureus and Staph. albus, which are now classified in separate 
genus Staphylococcus of the family Micrococcaceae. Julianelle in 1930 
introduced the first classification of staphylococci based on differences in 
antigenic structure, and in 1942, Fisk developed the method of typing 
them with bacteriophage (Davis, Mecarty and Wood,1973). 
1.5.2. Classification of staphylococci: 
          According to Smith et al. (1986), the Family: Micrococcacae 
includes four genera Staphylococcus, Micrococcus, Stomatococcus and 
Planococcus. 
 Many distinguishing features can differentiate staphylococci from 
micrococci; staphylococci ferment glucose anaerobically while 
micrococci attack glucose only oxidatively. Other tests include 
production of acetyl methyl carbinol (acetoin), oxidase, sensitivity to lytic 
substances and serology. Staphylococci are resistant to lysozyme while 
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micrococci are sensitive (Fleming, 1961). Staphylococci are sensitive to 
lysostaphin while micrococci are resistant (Schindler and Schuhardt, 
1964). Antibiotic sensitivity test may help in the differentiation between 
the two genera. Schleifer and Kloos (1975) found that staphylococci have 
greater sensitivity to erythromycin of (0.4 µg /ml) than micrococci. 
Similarly, Falk and Guering (1983) reported the sensitivity of 
staphylococci to bacitracin. 
       Serological tests have been used to distinguish micrococci from 
coagulase-negative staphylococci (Nakhla, 1973).  
1.5.3. Morphological and cultural characteristics: 
        A single colony of staphylococci is usually circular smooth raised 
surface and opaque within 24 hours of incubation. Encapsulated strains 
produce more convex and smaller colonies with wet glistening 
appearance (Smith et al., 1986). Colony size has been used as a 
differential character to separate them into greater or lesser than 5mm, 
especially if well isolated colonies were allowed to develop for several 
days at incubation temperature 30-35Cº followed by two days at room 
temperature (Kloos, Schleifer, and Noble, 1976 and Kools, 1985). 
1.5.4. Biological and biochemical characteristics: 
1.5.4.1. Pigmentation: 
 Pigment production is variable and wide range of pigmentation can 
be produced in subdued light at room temperature.  These pigments are 
known as lipochroms, they do not dissolve in water, but are soluble in 
ether, benzene, chloroform, acetone and alcohol (Pyatkin and Krivoschein, 
1987).  The presence of fermentable carbohydrate in the medium was 
found to enhance pigment production. But this fact was denied by 
O’connor and Smith (1986) who reported the importance of fatty acids in 
pigment production and recommended cream agar for better 
demonstration, while Pyatkin Krivoschein (1987) recommended potatoes 
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and milk agar media at temperature of 20ºC - 25ºC. 
1.5.4.2. Coagulase: 
 Staphylococci are divided into two groups based on the ability to 
produce the enzyme coagulase. This enzyme converts fibrinogen into 
fibrin causing blood plasma to clot. 
• Coagulase-positive staphylococci: 
 Coagulase-positive staphylococci are characterized by the 
production of the enzyme coagulase which converts fibrinogen in citrated 
human or rabbit plasma into fibrin by aiding an activator present in 
plasma (Wood et al., 1992). For many years any coagulase-positive 
Staphylococcus was regarded as Staph. aureus, but soon many other 
species were isolated later. Hajek (1976) described Staph. intermedius, 
Devriese (1977) and Devriese et al. (1979) described the coagulase 
variable Staph. hyicus in its coagulase-positive form. Varaldo et al. (1988) 
isolated a new species from dolphins and called it Staph. delphini. 
Recently, Staph. schleiferi-subsp-coagulans, which is coagulase-positive, 
has been reported (Gyles et al., 1993). There were reports about 
coagulase-negative Staph. aureus (Salamah,1990), but Staph. hyicus 
seem regularly to exist as coagulase-positive or coagulase-negative 
variants (Noble,1990).  Staph. aureus, Staph. intermedius, Staph. delphini 
and the coagulase variable species Staph. hyicus are regarded as 
opportunistic pathogens. They are found normally in humans specially 
those who are in contact with laboratories and patients (Huda, 1997; Hind, 
1997). Approximately 30% of healthy people are carriers of Staph. 
aureus (Wood et al.1992). At the same time, they are responsible for 
scalded skin syndrome, toxic shock syndrome (TSS) and skin infection 
(Jawetz et al., 1990). Other species like Staph. intermedius, described by 
Hajek (1976), are predominant pathogens of dogs causing pyoderma and 
other skin infection. Staph. delphini was isolated form suppurative lesions 
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in dolphins. 
• Coagulase-negative staphylococci:  
           Coagulase-negative staphylococci are characterized by failure to 
coagulate plasma (wood et al., 1992). They form a large group of more 
than 20 species, which are considered as normal flora. They are generally 
non-invasive under normal conditions. However, they may cause severe 
infections (Wood et al., 1992). Seventy five percent of infections caused 
by coagulase-negative staphylococci are due to Staph.epidermidus (Wood 
et al., 1992; Geo et al., 1998). It was found in pure culture of wound 
infections (Wilson et al., 1965). It also causes infection after surgery 
leading to post operative endocarditic and renal infection (Arbuthnott, 
1992; pulverer et al., 1967). Most of the remainder are identified as Staph. 
Simulans, Staph. warneri, Staph.  capitis,  Staph. xylosus. Staph. 
haemolyticus and Staph. auricularis. They are less common causers of 
infections (Kloos et al., 1975a , 1975b). Staph. saprophyticus is relatively 
a common cause of urinary tract infections in young woman (Barid and 
Parker, 1974; Arbuthnott, 1992; and Geo et al., 1998). Sneath et al. (1986) 
isolated Staph. carnosus form dry sausage. Kloos et al. (1976) 
characterized Staph. Lentus and Devriese et al. (1978, 1985) isolated 
Staph. Sciuri, Staph. hyicus and Staph. chromogenes from animal skin 
flora. Further three species were recorded by Schleiferi (1984) and these 
were Staph. arlettae,  Staph. kloosii and Staph. Eguroum. Moreover, 
Staph. schileferi and Staph. lugdunensis were described by Freney et al. 
(1988). Staph. lugdunensis was first identified as Staph. aureus and was 
regarded as the etiological agent of 20 cases of left sided endocarditis 
(Cooper et al., 1998 ). Kloos et al. (1983) isolated Staph. auricularis 
form ears and Klipper et al. (1981) brought Staph. saccharolyticus into 
the genus. Igimi et al. (1989) reported about Staph. felis in cat.  
      The coagulase-negative staphylococci are morphologically similar to 
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Staph. aureus and their methods for isolation and identification are the 
same. They can be distinguished from Staph. aureus by their lack of 
deoxy ribonuclease and their colonies are usually non-pigmented (white). 
 In (1968), Kleck and Donahue examined Staph. epidermidis from 
nasal carriers and other specimens from clinical materials most of which 
were from cases of endocarditis (Kleck and Donahue,1968).  They 
concluded that coagulase-negative staphylococci cultures obtained from 
normal nasal flora of human and from clinical sources were similar in 
their biochemical characteristics and in their ability to produce 
haemolysis. 
1.5.4.3. Catalase: 
             Since early 1950s there has been a general agreement that 
staphylococci are catalase-positive, but Smith et al. (1986) isolated 
several catalase-negative strains from diseased animals. 
1.5.4.4. Voges Proskauer (VP) test: 
          The production of acetoin from glucose in VP test has been used as 
a valuable character for separating staphylococci from micrococci (Kocur 
and Martinee, 1962).  In addition, it has been mentioned as one of the 
characters that can identify Staphylococcus species that infect man 
(Barrow and Felthame, 1993). Under certain conditions (incubation in 
phosphate free medium for up to 14 days) all staphylococci are positive 
except Staph. intermedius, Staph. hyicus and Staph. simulanse which are 
usually associated with animals while micrococci are negative except 
Micrococcus kistinae (Barrow and Feltham, 1993). 
1.5.4.5. Staphylococcal Antigens, Toxins and Enzymes: 
1.5.4.5.1. Antigens: 
 Jawetz et al. (2001) reported that staphylococci contain antigenic 
polysaccharides and proteins as well as other substances important in cell 
wall structure. These antigens include the peptidoglycan, techoic acid and 
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protein A as cell wall components and the capsules. 
1.5.4.5.2. Toxins: 
 The pathogenic effect of staphylococci depends upon the toxins 
and enzymes produced by bacteria (Merchant and Packer, 1969). The 
toxins are: haemolysin, leukocidin, enterotoxins and toxic shock 
syndrome toxin. 
1.5.4.5.3. Enzymes: 
         Staphylococci produce many enzymes which include coagulase, 
hyaluroindase, lipase, protease and fatty acid modifying enzyme (FAME). 
The later (FAME) is produced by certain strains of Staph. aureus to 
inactivate the bactericidal fatty acids produced in staphylococcal abscess 
(Mortensen et al., 1992).  
1.5.5. Nasal carriage of staphylococci: 
Apart from a few studies, notably those of Millian, Valkenbury and 
Wolters, (1960) and Noble et al. (1967), staphylococcal carriage has most 
often been investigated in patients and hospitals staff, and little attempts 
have been made to assess the frequency of factors other than age that 
might affect its frequency in healthy persons in the general population. 
Paul, Lamikanra and Aderibigbe, (1982), however, provided evidence 
suggesting that occupation had a significant effect on this carriage. 
Lamikanra (1985) found that the nasal carriers-rate of Staph. aureus in 
548 Nigerians aged 9-32 years and attending various educational 
establishment was 56,4%.This rate decreased with increasing age. A 
significantly greater proportion of females (65%) than males (46.5%) 
were carriers, but the excess in females was apparent only in subjects age 
>20 years. 
       From January to December 1994, 752 consecutive patients admitted 
to intensive care units (ICU) in Spain for more than two days were 
studied prospectively for Staph. aureus colonization and infection. Nasal 
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swabs were obtained at admission and weekly during (ICU) stay 
(Corbella, et al, 1997). At ICU admission 166 patients (22.1%) were 
Staph. aureus nasal carriers, while 586 were free of nasal colonization. Of 
the 166 nasal carriers, 163 harboured methicillin- sensitive Staph. aureus 
(MRSA). During the ICU stay 24 of 586 non-colonized patients become 
nasal carriers (11 methicillin sensitive Staph. aureus (MSSA) and 13 
methicillin resistant Staph. aureus (MRSA)), and one nasal carrier 
initially colonized by MSSA was decolonized by MRSA. Staphylococcal 
infections were documented in 51(6.8%) of the total 752 patients. After 
14 days, of ICU stay, the probability of developing staphylococcal 
infections was significantly higher for those patients who were nasal 
carriers at ICU admission than for those found to be initially negative. In 
patients with ICU-acquired nasal colonization, most infections were 
documented prior to or at the time of the detection of the nasal 
colonization. Thus in this group of patients nasal carriage showed lower 
predictive value for subsequent Staph. aureus infection, that described 
classically. Paired isolates of nasal colonizing and clinical strains were 
studied by pulsed field gel electrophoresis (PFGE) and 
mecapolymorphism analysis in 30 patients; identity was demonstrated in 
all but two patients. The results suggest that outside the setting of an 
outbreak of  MRSA, the detection of Staph. aureus nasal carriers on 
admission may be particularly useful in identifying those patients who are 
at high risk for developing staphylococcal infections during their ICU 
stay (Corbella, et al,1997). 
Another study on Staph. aureus nasal carriage distinguished three 
carriage patterns: persistent, intermittent and non-carriage (Vanden-Bergh 
et al, 1999). The criteria used to identify these carriage patterns were 
inconsistent. In 1988, the Staph.aureus nasal carrier index (i.e., the 
proportion of nasal swab specimen cultures yielding Staph. aureus was 
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determined for 91 staff members of various departments of a large 
University Hospital by obtaining weekly nasal swab specimens for 
culture over a 12 week period. Thirty- three (36%) persons had carrier 
indices of 0.80 or higher, 15 (17%) had indices between 0.1 and 0.7, and 
43 (47%) had indices of zero. In 1995, individuals with carrier indices of 
0.80 or higher in 1988 were available for re-examination. From 12 (71%) 
of these individuals, Staph. aureus was again isolated from a single nasal 
swab, i.e. from each individual with a 1988 carrier index of 1.0 but from 
only half of those with indices below one. Genotyping (by randomly 
amplified polymorphic DNA analysis and pulsed field gel electrophoresis) 
of all Staph. aureus strains showed that strains isolated from only three 
individuals, all with 1988 carrier indices of 1.0, in 1988 and 1995 showed 
genetic similarity. Vanden and his colleagues concluded that persistent 
Staph. aureus  nasal carriage is a unique characteristic of fraction of the 
population, and the attribute (persistent) should be confined to those 
individuals for whom serial nasal swab specimen cultures consistently 
yielded Staph. aureus. 
Sheretz, et al. (1996) reported outbreaks of Staph. aureus  skin 
infections that affected new born infant and were attributed to an Staph. 
aureus  nasal carrier, who had an associated upper respiratory tract 
infection (URI) during the outbreak period.  
Tewodros and Gedebou (1984) showed that in the surgical staff of 
five different hospitals and university biology students screened for nasal 
carriage of Staph. aureus., 32.4% and 21.6% were carriers respectively. 
The rate for the hospital staff was significantly higher. The carrier rates 
among the surgical staff varied between 59.1% for surgeons and 22.7 for 
other surgical staff.  
An epidemic of bullous impetigo caused by penicillin / tetracycline 
resistant strains of Staph. aureus occurred in a newborn nursery in 
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Louisville, Kentucky. Infants at risk developed disease during the six-
month epidemic period. Clinically, all case-infants had bullous impetigo 
skin lesions. One infant developed staphylococcal septicemia, but no 
infant died. An epidemiological investigation identified a nurse as having 
significantly greater contact with case infant than control infant 
(P<0.0013). She was found to be a nasal carrier of the epidemic strain. 
Infection control measures appeared to decrease infant to infant 
transmission via the hands of non-colonized nurses, but did not affect 
transmission from the nurse carrying the epidemic strain to infants. No 
cases of bullous impetigo have occurred since this nurse was temporarily 
removed from the nursery for treatment (Nakashima, et al, 1984).  
Murthy et al. (1999) found that nasal colonization with Staph. 
aureus at the time of severe head injury increases the risk of Staph. 
aureus   pneumonia during hospitalization. Prophylactic measures against 
Staph aureus pneumonia may help to reduce the length and cost of 
hospitalization.  
A longitudinal study was conducted on healthy Staph. aureus 
carriers among the students of nursing aid course to determine the extent 
of colonization by Staph. aureus and the evaluation of carrier status 
among them during their professional training. Forty students participated 
in the study. Samples were collected from their nasal cavity and right and 
left hands at six different times during the technical nursing course. 
Nineteen students (45%) were found to be occasional carrier, 12 (28.6) 
were intermittent carriers, 6 (14.3%) were persisters, and 5 (11.9%) were 
non- carriers. These results have shown that colonization did not increase 
during the course. Twenty- four of persons (57.1%) did not perform 
activities related to nursing before or during the course, whereas, 18 
(42.9%) performed (Santos, 1999). 
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Kolmos (1999) found that 20% of the normal population are nasal 
carriers of Staph. aureus and the carrier rate is even higher in insulin 
dependent diabetics, intravenous drug addicts patients, in haemo and 
peritoneal dialysis and HIV infected patients. Nasal Staph. aureus carriers 
have an increased risk of  Staph. aureus infections following invasive 
therapy. Mupirocin, a novel topical antibiotic, is highly effective against 
nasal Staph. aureus. A number of studies indicated that it might reduce 
the incidence of Staph. aureus infections in dialysis patients. However, 
experience with other categories of patients is spares. Surgical wound 
infection with Staph. aureus is particularly a serious complication after 
implantation of foreign body material, e.g. artificial joints. There is a need 
for controlled clinical trials to improve the efficacy of mupirocin in 
eradicating Staph. aureus in these types of patients. The investigators 
recommended that uncritical use of mupirocin for topical treatment of 
wounds should be avoided in order to prevent development of resistant 
strains. 
Chapoutot et al. (1999) showed that a cirrhotic liver patient has a 
higher Staph. aureus nasal carriage rate than controlled subjects previous 
hospitalization. Cirrhosis diagnosis was correlated to nasal colonization. 
 Richardson et al. (1990) reported that an outbreak of skin infection 
caused by beta-Lactamase negative strain of methicillin resistant Staph. 
aureus (MRSA) occurred during a five week period in a newborn nursery. 
Twelve babies, two mothers and two members of staff were involved. 
One baby had a diagnosis of staphylococcal scalded skin syndrome and 
two others required treatment with antibiotics. The infecting strains 
produced exofoliative toxin A. It was thought that a nasal carrier had 
introduced it from a different maternity unit. Laboratory investigations 
tended to support this hypothesis.  
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On the other hand, nasal carriage of Staph. intermedius in humans 
in contact with dogs was studies by (Harvey, Marples and Noble, 1994). 
From sixteen dog owners, whose dogs were with a topic dermatitis and 
positive for Staph. intermedius, one owner was a persistent nasal carrier 
and four were transient nasal carriers of Staph. Intermedius, and four 
were persistent nasal carriers and one was a transient carrier of Staph. 
aureus. Of 13 veterinary staff regularly exposed to dogs, one was 
persistent carrier and two were transient carriers of Staph. aureus. 
The incidence of nasal carriage of Staph. aureus outside the hospital 
environment in Egypt showed high rates of coagulase-positive 
staphylococci isolated from newborns in nursery operating theatre staff, 
haemodialysis unit, and cancer patients receiving chemotherapy and staff 
members in surgery, chest and internal medicine department. It also 
showed significant difference in isolation rates between patients at 
hospital and controls (normal population) (Ali et al., 1993). 
 1.5.6. Staphylococci in the Sudan: 
        Many studies were carried out in the Sudan concerning 
staphylococci which were isolated from many disease conditions and the 
environment.  
  a. Staphylococcus aureus: 
It was isolated by Huda (1997) from medical laboratories 
environment, by Ra`ad (1997) from human abscess, and by Reem (2000) 
from human nose.  
b. Staphylococcus caseolyticus: 
It was isolated by Kamal (1995) from the eye, ear, nose, mouth and 
abscess. Samia (1997) isolated it from ice cream, sausage minced meat. 
Selma (2000) recovered it from intestines of cattle, sheep, goats, poultry 
and camels. Huda (1997) isolated it from medical laboratories 
environment, and by Noura (1997) from abscess. Ra`ad (1997) isolated it 
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from human abscess and nose, and by Reem (2000) from human nose. 
c. Staphylococcus gallinarum:     
It was isolated by Huda (1997) from medical laboratories 
environment, by Kamal (1995) from skin. Samia (1997) isolated it from 
yogurt and Mohamed (1998) isolated it from bumble-foot of poultry.  
d. Staphlococcus schleiferi:  
It was isolated by Kamal (1995) from the eye, ear, nose and skin 
and by Nora (1997) from abscess. Hind (1997) isolated it from human 
abscess, axilla, ear, eye, and face, and by Reem (2000) from human nose. 
e. Staphylococcus lugdunensis: 
It was isolated by Huda (1997) from medical laboratories 
environment and by Ra`ad (1997) from human nose and abscess.  Hind 
(1997) isolated it from human abscess urinary pathogen, ear, groin and 
nose, and by Reem (2000) from human nose. 
f. Staphylococcus chromogens: 
It was isolated by Huda (1997) from medical laboratories 
environment, and by Samia (1997) from ice cream and by Hind (1997) 
from human ear, groin, nose, abscess and urine. 
g. Staphylococcus epidermidis: 
It was isolated by Kamal (1995) from the eye, throat, nose, ear, and 
skin, and by Reem (2000) from human nose. Selma (2000) isolated it 
from fecal specimens of human. 
h. Staphylococcus auricularis: 
It was isolated by Hind, (1997) from human axilla, ear, face, nose 
and urine, and by Kamal (1995) from the ear, nose, eye, and throat. Huda 
(1997) isolated it from medical laboratories environment. 
i. Staphylococcus haemolyticus: 
It was isolated by Kamal (1995) from skin and by Hind (1997) 
from axilla, nose, and urine. 
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j. Stapylococcus lentus: 
It was isolated by Huda (1997) from medical laboratories 
environment, and by Kamal (1995) from the eye, throat, milk and faeces. 
Samia (1997) isolated it from minced meat and by Hind (1997) from 
human mouth and throat. 
k. Staphylococcus intermidius: 
It was isolated by Hind (1997) from human eye, and by Huda 
(1997) from medical laboratories environment, by Samia (1997) from 
sausage, by Ra`ad (1997) from human nose, by Kamal (1995) from skin 
and by Noura (1997) from abscess. 
l. Staphylococcus sciuri: 
It was isolated from abscess by Noura (1997), by Kamal (1995) 
from the eye, ear, nose, and feces, by Samia (19970 from beef burger, 
sausage, ice cream and dandorma, by Huda (1997) from medical 
laboratories environment and by Selma (2000) from intestinal specimens 
of cattle. 
m. Staphylococcus kloosii: 
It was isolated by Huda (1997) from medical laboratories 
environment and by Hind (1997) from human mouth and urine. 
n. Staphylococcus saprophyticus: 
It was isolated by Kamal (1995) from skin, by Huda (1997) from 
medical laboratories environment and by Samia (1997) from dandorma. 
o. Staphylococcus caprae: 
It was isolated by Kamal (1995) from skin and by Hind (1997) 
from human ear and eye.  
p. Staphylococcus hyicus:  
 Staph. hyicus (coagulase-positive) was isolated by Samia (1997) 
from beef burger and by Reem (2000) from human nose. 
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1.5.7. Antibiotic susceptibility of staphylococci:  
      This is not generally regarded as good and reliable taxonomic 
criterion because of its instability due to resistance of gene carrying 
plasmids. Some antibiotic resistance is intrinsic and determined by 
chromosomal genes and hence are stable. These can serve as taxonomic 
characters, for example novobiocin resistance is a characteristic of Staph. 
saprophyticus, Staph. cohni, Staph. xylosus, Staph. kloosii, Staph. 
eguorum, Staph. arlettae, Staph. gallinarum, Staph. lentus, and Staph. 
sciuri. The MIC for novobiocin resistance ranges from 1.6 to 6.4 µg/1ml 
(Kloos and Schleifer, 1975; Schleifer and Kloos, 1975). Rapid tests have 
been developed for the detection of novobiocin–resistance for 
presumptive identification of Staph. saprophyticus from clinical 
specimens (Almeda and Jorgensen , 1983; Harrington and Gaydos, 1984). 
 Schleifer and kloos (1975) reported a distinguishing feature for 
staph. epidermidis complex; almost all strains are sensitive to novobiocin 
up to 1.6 µg /ml, Staph. saprophyticus species group also exhibt 
anomalous resistance to penicillin and fusidic acid (Richardson and 
Marples,1980). Staph. cohni and Staph. xylose are intrinsically resistant 
to lincomycin while Staph. saprophyticus is susceptible unless an 
erythromycin resistance or lincosamide inactivating gene is present. 
 Penicillin resistance is due to the production of beta lactamase. An 
evidence of a common gene pool was observed; i.e. the appearance in 
hospital strains of coagulase-positive and negative staphylococci with 
similar plasmids mediating specific resistance (Mc Donnel, Sweeney and 
Cohn., 1983). Noble (1977) reported that penicillin resistant Staph. 
aureus is more common on the skin than on the nose of dermatology 
patients. Further, Noble (1981) reported that Staph. aureus strains 
aquiring penicillinase plasmids are more common on the skin than nose.  
 According to Lacy (1982, 1983) among the antibacterials 
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recommended for staphylococcal pneumonia, septicaemia, arthritis and 
bone infections after surgery were cloxacillin and penicillin (oral). 
 While erythromycin has no toxic effect of any consequences 
reported from its administration, but because of development of resistant 
strains of bacteria, its use was limited. 
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CHAPTER TWO 
 
MATERIALS AND METHODS 
2.1. Asepsis and sterilization: 
2.1.1. Hot air oven: 
Glassware as petri dishes, pipettes, tubes, flasks, glass-rods were 
sterilized in the hot air oven at 160 ºC for two hours. 
2.1.2.   Autoclaving: 
 Media, solutions, screw-capped bottles were sterilized by 
autoclaving at 121º C for 15 minute. Sugar containing media were 
autoclaved at 110º C for 10 minutes.   
2.1.3. Irradiation and disinfectants: 
 Phenolic disinfectants and 70% alcohol were used first for 
disinfecting floors and benches of the UV-light room followed by UV 
irradiation for 20 minute to sterile the vacuum of the room. 
2.2. Perpetration of media: 
2.2.1. Solid media: 
2.2.1.1. Baird-Parker`s medium: 
In a liter of distilled water, sixty three grams of dehydrated Baird-
Parker`s medium (Oxoid) were suspended, mixed, and steamed to 
dissolve. The pH was adjusted to 6.8 before autoclaving at 121º C for 15 
minutes. After cooling to about 45ºC, 5 ml of egg-yolk emulsion and 2 ml 
of potasium-tellurite were added aseptically and mixed well before 
pouring into sterile plates in 15 ml amounts. 
2.2.1.2. Blood agar: 
Forty grams of blood agar base (Oxoid) were suspended in a litre 
of distilled water, steamed to dissolve, cooled and the pH was adjusted to 
7.4. It was then sterilized by autoclaving at 121º C for 15 minutes. After 
cooling to about 45ºC, defibrinated sheep blood was added aseptically in 
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7-10 % concentration before pouring into sterile plates in 15 ml amounts. 
2.2.1.3. Nutrient agar: 
Twenty-eight grams of dehydrated nutrient agar (Oxoid) were 
suspended in a litre of distilled water, steamed to dissolve completely, the 
pH was  adjusted to 7.4 and then the medium was  autoclaved at 121º C 
for 15 minutes. It was then poured into sterile plates in 15 ml amounts. 
2.2.1.4. DNAse agar: 
Thirty-nine grams of DNAse agar (Oxoid) were suspended in one 
litre of distilled water and boiled to dissolve completely. The media was 
sterilized by autoclaving at 121ºC for 15 minutes then poured into sterile 
plates in 15 ml amounts. 
2.2.1.5. Urea agar:  
An amount of 2.4 grams was  suspended in 95 ml of distilled water, 
boilded to desolve completely, sterilized by autoclaving at 115ºC for 20 
minutes, cooled to 45ºC and 5 ml of sterile 40% urea solution was added 
aseptically, mixed well, then distributed into sterile bijou bottles and 
allowed to set in slope position.  
 2.2.1.6. Diagnostic Sensitivity Test (DST) agar: 
 Forty grams of DST agar base (Oxoid) were suspended in a litre of 
distilled water and steamed to dissolve completely. It was then sterilized 
by autoclaving at 121º C for 15 minutes. The medium was then poured 
aseptically into sterile plates in 15 ml amounts. 
2.2.2. Semi solid media: 
2.2.2.1. Hugh and leifson`s (O/F medium): 
It consisted of peptone two grams, NaCl five grams, K2HPO4 0.3 
grams, agar three grams and distilled water 1000 ml, bromothymol blue 
0,25% aqueous solution 15 ml. The ingredients were steamed to dissolve; 
the pH was adjusted to 7.1. The indicator was added to the medium which 
was sterilized by autoclaving at 115º C for 20 minutes. Ten ml of sterile 
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glucose solution was aseptically added to 90 ml of the medium to give a 
final concentration of 1%. It was then distributed into sterile test tubes in 
10 ml amounts. 
2.2.3. Liquid media: 
2.2.3.1. Nutrient broth: 
Thirteen grams of dehydrated nutrient broth (Oxoid) was 
suspended in a liter of distilled water, mixed well and the pH was 
adjusted to 7.4. The medium was distributed in 10 ml amounts into test 
tubes then sterilized by autoclaving at 121 ºC for 15 minutes. 
2.2.3.2. Peptone water: 
Fifteen grams of dehydrated peptone water (Oxoid) were 
rehydrated in a liter of distilled water and mixed well. The pH was 
adjusted to 7.2 and the medium was distributed in test tubes in 10 ml 
amounts then autoclaved at 121 ºC for 15 minutes. 
2.2.3.3. Glucose Phosphate medium: 
It consisted of peptone 10 grams, K2HPO4   5 grams, distilled 
water 1000 ml. The mixture was steamed to dissolve and the pH was 
adjusted to 7.5. 5 grams of glucose were added, mixed and distributed 
into test tubes in 10 ml amounts and sterilized at 110º C for 10 minutes. 
2.3. Samples of the study: 
 Samples were collected from Omdurman Teaching Hospital during 
the period between February to July 2006. A total of sixty swab samples 
were collected from the nasal cavity of 50 hospitalized patients and 10 
healthy individuals in the State (table 2.1). In the hospital, samples were 
collected from patients who comprised 4 groups: 
- Group (1): spent a week in the hospital. 
- Group (2): spent 2 week in the hospital. 
- Group (3): spent 3 week in the hospital. 
- Group (4): spent 4 week in the hospital. 
 23
 
Table (2.1): source and numbers of swab samples collected in the 
study: 
 
Source of 
samples 
Number of 
samples 
Gender Age 
Hospital patient 50 Males and 
females 
18-75 
Healthy 
individuals 
10 Males and 
females 
18-50 
 
2.4. Collection and transport of samples: 
Nasal swabs were obtained by using sterile dry cotton-wool swab. 
Both the left and right anterior nares were swabbed by rubbing the swab 
four times around inside of each nostril and the swabs were immediately 
inserted into its container. Samples were transported at 4ºC immediately 
after collection to the Bacteriology lab., Dept. of Microbiology, F. Vet. 
Med., U.OF K.  
2.5. Cultivation of samples: 
 The samples were cultivated on the same day of collection. The 
swab was used to primary inoculate a Baird-Parker`s plate aseptically. 
The plate was then streaked from the primary inoculums using sterile 
wire loop, and then incubated aerobically at 37ºC for 24 hours. 
2.6. Purification and storage of isolates: 
 Colonies on Baird-Parker`s, that showed Gram-positive cocci were 
subcultured on blood agar and purified by repeated sub culturing on the 
later medium. Pure isolates were stored on nutrient agar slopes for further 
bacteriological investigation. 
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2.7. Identification of isolates:  
         Identification was carried out as described by Barrow and Feltham 
(1993).  
2.7.1. Microscopic examination: 
 Smears were prepared from cultures by emulsifying a part of 
colony in a drop of normal saline on a clean glass slide. The smear was 
allowed to dry, fixed by passing over the flame and then stained with 
Gram method (Barrow and Feltham, 1993). 
Crystal violate was added for 1 minute and washed with water. 
Then the slide was flooded with iodine for 1 minute and washed with 
water. For decolourization, acetone was added on slide for few seconds 
and washed immediately with water. Dilute carbol fuchsin was then 
added on the slide as a counter stain for half a minute, and then washed 
with water. The slide was then dried with filter paper and examined under 
microscope using the oil immersion objective lens. 
Gram-positive organisms appear violet, while Gram-negative 
organisms appear red. 
2.7.2. Cultural characteristics: 
The growth of isolates on Baird-Parker and blood agar was 
described and recorded for each and used to assess in the identification. 
2.7.3. Biochemical tests: 
2.7.3.1. Primary tests: 
2.7.3.1.1. Catalase test: 
           A drop of 3% aqueous solution of hydrogen peroxide was placed 
on a clean glass slide. A part of colony of the bacterium under test (grown 
on nutrient agar) was placed in the hydrogen peroxide drop using glass 
rod.  Production of gas bubbles indicated a positive result for the catalase 
test 
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2.7.3.1.2. Oxidase test: 
            The organism was grown on nutrient agar. A piece of filter paper 
approximately 7 cm in diameter was placed in Petri-dish and two to three 
drops of 1 % aqueous solution of tetramethyl p-phenylene diamine 
dihydrochloride was added. The test organism was picked with sterile 
bent glass rod and rubbed over the filter paper. A dark purple color that 
develops within 5-10 seconds was considered as a positive result.  
2.7.3.1.3. Oxidation/Fermentation (O/F) Test: 
         The test was made by growing the test culture in two tubes of Hugh 
and Liefson ́s medium. A layer of soft paraffin was added to one tube to a 
depth of about 1 cm. Both tubes were incubated at 37ºC and examined 
daily. Oxidizer organisms showed acid production in the open tube only; 
fermenters showed acid production in the paraffin-covered tube and in the 
open tube starting from the bottom.  
2.7.3.2. Secondary tests: 
2.7.3.2.1. Voges-Proskauer (VP) test: 
           The test organism was inoculated in test tube or screw-capped 
bottles containing 1.5 ml glucose phosphate broth and incubated at 37º C 
for two days. 0.2 ml of 40% KOH and 0.6 ml of 5% α-napthol solution 
were added to 1 ml of each culture, shacked and the tubes were placed in 
sloped position and examined after ten minutes. Positive test was 
indicated by strong red color.    
2.7.3.2.2. Sugar Fermentation test: 
          The peptone water sugar was inoculated with test culture. The 
culture was incubated at 37ºC and examined daily for up to seven days. 
Acid production was indicated by the development of a pink color in the 
media. 
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2.7.3.2.3. Coagulase test: 
         One ml fresh sterile human plasma was added to 9 ml sterile normal 
saline and the mixture was distributed in a series of small sterile 
agglutination test tubes that were incubated with test strains.   One ml of 
both was added to each of the test tubes which contained 1 ml of human 
plasma, then incubated at 37ºC. Coagulation was observed after an hour, 
then after 3 hours and finally after 24 hours of incubation. Positive and 
negative control was included. 
2.7.3.2.4. Urease test: 
            A urea agar slant was streaked with the test culture and incubated 
at 37º C for 24-48 hours.  The development of a pink color was indicative 
of production of NH3.  Negative and weak tests were left for a week 
before taking results.                                                                                                              
2.7.3.2.5. Deoxyribonuclease (DNAse) test: 
          DNAse test was used to differentiate Staph. aureus which produce 
the deoxyribonuclease (DNAse) enzyme from other staphylococci. The 
test was performed by culturing the organism on DNAse agar which 
incubated over night at 37º C. DNAse production was tested  by flooding 
the plate with 1M hydrochloride acid solution. The acid precipitates 
unhydrolyzed DNA. DNAse producing colonies were surrounded by 
clear areas indicating DNA hydrolysis.                
2.7.3.2.6. Novobiocin Sensitivity test: 
            This test was performed by the standard disc diffusion method.  
After DST agar plate was dried, sterile swab was soaked in 24 hours 
nutrient broth culture and use to inoculate evenly all over the surface of 
the medium, and then the plate allowed to dry. With the aid of sterile 
forceps, the disc “5µg” of Novobiocin was placed onto the surface of the 
medium and pressed gently. The medium was placed at room temperature 
for prediffusion for 15 minutes before incubated at 37ºC for 24 hours. 
 27
             Zone of inhibition was measured in millimeter and reporting 
sensitive or resistant.  
2.8. Antibiotic sensitivity test: 
 Sensitivity of 43 isolates to different antibiotics was determined 
by the standard disc diffusion technique (Cruickshank et al., 1975). The 
samples were grown on peptone water aerobically at 37º C for 24 hours. 
About 2 ml of the culture was poured on the surface of nutrient agar 
medium and evenly distributed by rotation. Excess fluid was withdrawn 
using Pasteur pipette and the plate was let to dry at room temperature for 
30 minutes. Commercially prepared discs (Abtek Biologicals Ltd) were 
placed on the surface of the medium by sterile forceps and pressed gently 
to insure full contact with the surface of the culture medium. The plates 
were then incubated aerobically at 37º C for 24 hours. 
The antibiotics used were: 
Chloramphenicol         10 µg                      Tetracycline       10 µg  
Gentamycin                  10 µg                        Ampicillin        10 µg  
Streptomycin               10 µg                       Penicillin            1 i.u 
Erythromycin              5   µg                        Cloxacillin          5 µg  
 The zone of growth inhibition was measured in millimeters and 
the bacteria were described accordingly as sensitive, resistant or 
intermediate (table 2.2) (Bauer et al., 1966). 
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Table (2.2): Standard zone of inhibition to different antibiotics (Bauer 
et al., 1966).  
Zone of inhibition (Diameter in mm) 
Antimicrobial agent 
Disk 
potency Resistant Intermediate Sensitive 
1- Ampicillin (AMP) 10 µg 22 or less 23 – 30 31 or more 
2- Penicillin (PEN)  1 i.u 20 or less 21– 28 29 or more 
3- Gentamycin (GEN) 10 µg 12 or less 13 – 14 15 or more 
4- Cloxacillin (CXC)  5 µg 9 or less 10 – 13 14 or more 
5- Erythromycin (ERY) 5 µg 13 or less 14 – 22 23 or more 
6- Streptomycin (STR) 10 µg 11 or less 12 – 14 15 or more 
7-Chloramphenicol 
(CHL) 
10 µg 12 or less 13 – 17 18 or more 
8- Tetracycline (TET) 10 µg 14 or less 15 – 18 19 or more 
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CHAPTER THREE 
RESULTS 
 3.1. Isolation and identification:       
 A total of sixty samples were collected. Fifty swabs were collected 
from patients in Omdurman Teaching Hospital, who were classified into 
4 groups according to duration of stay in the hospital. The other ten 
samples were collected from healthy individuals. 
 All samples were bacteriologically investigated staphylococci. 
  3.1.1 Isolates from patient groups: 
           A total of 60 staphylococci were isolated from the nostrils of the 
patients (table 3.1). Fifteen different species were isolated (table 3.2) 
(figure 3.1) and this included Staph. aureus and, Staph. hyicus (as 
coagulase-positive staphylococci) Staph. auricularis, Staph. caseolyticus, 
Staph. caprae, Staph. chromogens, Staph. epidermidis, Staph. gallinarum,  
Staph. haemolyticus, Staph. kloosii, Staph. lentus, Staph. lugdunensis, 
Staph. sciuri, Staph. chleiferi and Staph. saprophyticus (as coagulase-
negative staphylococci).  
         Staph. aureus was the predominant isolated species (33.3%) 
followed by  Staph. chromogens (16.7%) and  Staph. epidermidis (8.3%) 
and these  species were  isolated from all patient groups. 
        Certain species were isolated only from certain group of patients. 
Staph. gallinarum, Staph. lugdunensis, Staph. saprophyticus and Staph. 
lentus were isolated only from group 3. Staph. auricularis and Staph. 
capare were isolated only from group 1. 
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3.1.2 Isolates from Healthy individuals: 
         A total of 10 staphylococci were isolated from nostrils of healthy 
individuals and comprised 5 different species (table 3.3) which included 
Staph. aureus (3,30%), Staph. hyicus (1,10%), Staph. intermidius (1/10%) 
(as coagulase-positive staphylococci) and Staph. epidermidis (3,30%),  
Staph. lugdunensis (2/20%) (as coagulase-negative staphylococci). Staph. 
aureus and Staph. epidermidis were the predominant species isolated in 
this group each represented 30%  as shown in Fig (3.2). 
3.2 Microscopic appearance : 
        All isolated staphylococci appeared as Gram-positive cocci which 
arranged in clusters under the microscope. 
3.3 Cultural characteristics: 
         Colonial morphology of isolates on Baird-Parker and blood agar 
medium was observed and recorded in this study.  
 In general, on Baird-Parker` medium, all coagulase-positive 
staphylococci showed small to moderate size colonies. Staph .aureus 
showed two diagnostic characteristics. Firstly, a clear zone appeared 
around the colonies (due to proteolysis). Secondly, opaque zones appear 
within the clear zones (caused by lipase).  
 On blood agar coagulase-positive staphylococci grew forming 
convex, circular golden-yellow and opaque colony after 18-24 hours 
incubation at 37˚C. Twenty Staph. aureus isolates were recovered; 12 of 
them developed double zone of haemolysis and the rest developed only  
beta haemolysis.  
 Coagulase-negative type of staphylococci showed delayed growth 
on Baird-Parker medium forming brownish black and big colonies. 
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3.4 Biochemical tests results: 
      Isolated staphylococci in this study were identified using the primary 
and secondary tests as described in Barrow and Felthman (1993). All 
isolated staphylococci were catalase-positive, oxidase-negative except 
Staph. sciuri and Staph. caseolyticus which were both oxidase positive. 
Coagulase test acts as a key test in this study. Coagulase-positive 
staphylococci which include Staph. aureus, Staph.intermidius and Staph. 
hyicus were differentiated by two sugars namely  maltose and mannitol. 
Staph. aureus was positive for both, Staph. hyicus were negative for both 
and Staph. intermidius were positive for mannitol and negative for 
maltose.  
         All isolated staphylococci in this study were sensitive to novobiocin 
except Staph.saprophyticus, Staph. lentus, Staph. Gallinarum, Staph. 
kloosii and Staph. scuri. 
3.5 Antibiotic sensitivity test:  
        Forty-three representative isolates of staphylococci were subjected to 
sensitivity tests to different antibiotics. Results are shown in tables (3.4), 
(3.5), (3.6), (3.7) and (3.8) and figures (3.3), (3.4), (3.5), (3.6) and (3.7). 
       In general more than 90% of isolates from patients were found 
sensitive to gentamicin while all isolates (100%) from healthy individuals 
were found sensitive to the same antibiotic. 
       A varying degree of resistance to chloramphenicol was detected in 
isolates from patients while isolates from healthy individuals were either 
sensitive or moderately sensitive. 
        The resistance to penicillin and ampicillin increased in isolates from 
patients and proportionate with the duration of stay in the hospital. 
 Some isolates from patients showed varying degree of resistance to 
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cloxacillin while all isolates from healthy individuals were sensitive to 
the same antibiotic. 
 The antibiotic sensitivity tests of all isolates to streptomycin and 
erythromycin showed variable patterns.    
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Table (3.1): Source and number of isolated staphylococci from nasal         
Swab samples in the study                               
 
Source of samples No. of samples No. of isolates % of isolation
Patients  
           group (1) 17 17 28.3% 
           group (2) 11 16 26.7% 
           group (3) 15 16 26.7% 
           group (4) 7 11 18.3% 
              Total 50 60 100% 
Normal individuals 10 10 _ 
Total number of samples 
and isolates 60 70 _ 
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Table (3.2): Staphylococcus species isolated from different groups of    
patients in the study. 
 
Species Group(1) Group(2) Group(3) Group(4) Total Percentage
S. aureus 8 3 4 5 20 33.3 
S. auricularis 2 0 0 0 2 3.3 
S. caseolyticus 1 0 2 1 4 6.7 
S. caprae 1 0 0 0 1 1.7 
S. chromogens 2 5 2 1 10 16.7 
S. epidermids 1 2 1 1 5 8.3 
S. gallinarum 0 0 1 0 1 1.7 
S. haemolyticus 1 2 0 0 3 5 
S. hyicus 0 3 1 1 5 8.3 
S. kloosii 0 0 1 1 2 3.3 
S. lentus 0 0 2 0 2 3.3 
S. lugdunensis 0 0 1 0 1 1.7 
S. sciuri 1 0 0 1 2 3.3 
S.saprophyticus 0 0 1 0 1 1.7 
S. schleiferi 0 1 0 0 1 1.7 
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Table (3.3): Staphylococcus species isolated from healthy individuals. 
 
Percentage Number Species 
30% 3 Staph. aureus 
30% 3 Staph. epidermidis 
10% 1 Staph. hyicus 
20% 2 Staph. intermidius 
10% 1 Staph. lugdunensis 
100% 10 Total 
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Table (3.4): Antibiotic sensitivity test of Staphylococcus species 
isolated from group ( 1). 
 
     (%) AMP CHL CXC ERY GEN PEN STR TET 
Sensitive 18.2 72.7 72.7 9.1 90.9 0 54.55 36.4
Intermediate 27.3 0 18.2 36.4 0 36.4 9.1 18.2
Resistant  54.5 27.3 9.1 54.5 9.1 63.6 36.4 45.4
 
 
 
Table (3.5): Antibiotic sensitivity test of Staphylococcus species 
isolated from group ( 2). 
 
       (%) AMP CHL CXC ERY GEN PEN STR TET 
Sensitive  0 66.7 55.6 11.1 88.9 0 66.7 11.1
Intermediate 66.7 11.1 0 55.6 0 33.3 0 33.3
Resistant  33.3 22.2 44.4 33.3 11.1 66.7 33.3 55.6
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Table (3.6): Antibiotic sensitivity test of Staphylococcus species 
isolated from group ( 3). 
 
       (%) AMP CHL CXC ERY GEN PEN STR TET 
Sensitive 0 40 100 10 100 10 80 30
Intermediate 20 30 0 60 0 40 0 20
Resistant 80 30 0 30 0 50 20 50
 
 
 
Table (3.7): Antibiotic sensitivity test of Staphylococcus species 
isolated from group ( 4). 
 
    (%) AMP CHL CXC ERY GEN PEN STR TET 
Sensitive 0 44.4 66.7 22.2 100 0 55.6 22.2
Intermediate 22.2 44.4 11.1 44.5 0 11.1 0 44.5
Resistant 77.8 11.2 22.2 33.3 0 88.9 44.4 33.3
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Table (3.8): Antibiotic sensitivity test of Staphylococcus species 
isolated from healthy individuals. 
 
      (%) AMP CHL CXC ERY GEN PEN STR TET 
Sensitive 0 50 100 0 100 0 25 0 
Intermediate 50 50 0 75 0 50 50 0 
Resistant 50 0 0 25 0 50 25 100 
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Staph.aureus
Staph.auricularis
Staph.caseolyticus
Staph.caprae
Staph.chromogens
Staph.epidermids
Staph.gallinarum
Staph.haemolyticus
Staph.hyicus
Staph.kloosii
Staph.lentus
Staph.lugdunensis
Staph.sciuri
Staph.saprophyticus
 
              Fig (3.1): Staphylococcus species isolated from different 
groups of patients in the study. 
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 Fig (3.2): Staphylococcus species isolated from healthy individuals. 
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Fig (3.3): Sensitivity test result for Staphylococcus species 
isolated from group (1). 
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Fig (3.4): Sensitivity test result for Staphylococcus species 
isolated from group (2). 
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Fig (3.5): Sensitivity tests results for staphylococcus species 
isolated from group (3). 
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Fig (3.6): Sensitivity tests results for staphylococcus 
species isolated from group (4). 
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Fig (3.7): Sensitivity tests results for staphylococcus species 
isolated from healthy individuals.
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CHAPTER FOUR  
DISCUSSION  
          
Although Staphylococci are normal flora of skin and mucous 
membranes of man and animal body, some of them have been associated 
with many health problems. They might cause disease by their presence 
in the animal body or by contaminating the food. 
  Staphylococcal infections cause significant morbidity and mortality 
in both the community and hospital setting (Cosgrove et al., 2003). 
Screening for staphylococci among various patients populations has 
become important for appropriate therapeutic management and for 
epidemiological reasons.  
  In this study, 16 different species of staphylococci were isolated 
from the nasal cavity of patients and normal individual in Khartoum State. 
Staph.  aureus was the most common isolated  species from the nasal 
cavity of patients and normal individuals  ( accounted for 33.3% and 30% 
of isolates respectively). This finding agreed with that of many studies () 
and confirmed the fact that Staph. aureus is a frequent commensal of the 
skin and mucous membranes of man, especially of the upper respiratory 
and digestive tracts (Carter and Wise, 2004). Lamikanrg (1985) and 
Reem (2000) isolated it frequently from the nasal cavity of men in 
Nigeria and Sudan respectively. Wood et al. (1992) reported that 
approximately 30% of healthy people are carrier's Staph .aureus.  
       Staph. intermidius was isolated from healthy individuals 
only (counted for 20% of isolates). It was a common commensal 
of oral, nasal, and skin flora in healthy dogs, where it can also 
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cause invasive disease (Hajek, 1976; Rausa and Love, 1993; 
Talan et al., 1989). In Human, it was recognized as an invasive 
zoonotic pathogen and was isolated form 18% of canine. 
infected wounds (Lee, 1994). Other reports of invasive human 
disease include pneumonia following coronary artery bypass, 
grafting and catheter related bacteremia in a patient with lung 
cancer (Gerstadt et al., 1999; Vandenesch et al., 1995). 
         Staph. hyicus ranked in third position of isolates from 
patients (8.3%) and healthy individuals (10%). It was isolated 
by Reem (2000) from human nose and Huda (1997) and Hind 
(1997) reported the occurrence of this Staph. in human specially 
those who are in contact with laboratories and patients. 
Deviriese et al. (1978, 1985) isolated it from animal skin flora. 
It was reported to cause various skin infections of animals 
(Carter and Wise, 2004).  
        Many coagulase-negative staphylococci were isolated in 
this study. Recently, the coagulase negative staphylococci have 
been studied extensively because of their pathogeincity and 
involvement in some kinds of human and animal diseases 
(Buttery et al., 1997; Kloos and Bannerman 1994; Mahoudeau 
et al., 1997; Pfaller and Herwaldt, 1988).  
       Staph. epidermidis was one of the most common species 
(30%) in healthy individuals and it ranked third in patients 
(8.3%). This finding urged the previously mentioned fact that 
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this species is found commonly on the skin of humans (Carter 
and Wise, 2004). It was isolated in the Sudan from different 
sites of the human and animal body (Kamal, 1999; Reem, 2000; 
Selma, 1997). Staph. epidermidius was described as an 
occasional opportunistic from abscesses in various sites 
including wounds (Wilson et al., 1965; Carter and Wise, 2004). 
75% of infections caused by coagulase-negative staphylococci 
were due to Staph. epidermidis (Wood et al., 1992; Geo et al., 
1998). Staph. epidermidis followed by Staph. haemolyticus, are 
the commonest coagulase-negative species associated with 
human infections (Nord et al., 1976; Marple and Richardson, 
1981).  
Staph. caprae was originally isolated from goat milk in 
1983 (Devriese et al., 1983) and has been primarily associated 
with animals, and infrequently associates with humans. The 
infrequent human infections include bone and joint (Blanc et al., 
1999; Eisner et al., 1998;), sepsis and bacteremia (Raimundo et 
al., 2002), recurring sepsis (Takemura et al., 2000), urinary tract 
infections (Vandenesch et al., 1995), endocarditis  (Vandenesch 
et al., 1995), and cases of acute otitis externa (Roland and 
Stroman, 2002). Most infections have been hospital acquired, 
although a few community-acquired infections have been 
documented. Only a few researchers have reported Staph. 
caprae strains isolated from human clinical specimens (Behme 
et al., 1996; George and Kloos 1994; Vandenesch et al., 1995).  
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        Members of the Staphylococcus sciuri group, Staph. sciuri, 
Staph. lentus, Staph. pulvereri (Kwok and Chow, 2003), are 
principally animal species (Devriese et al., 1989; Kloos, 1980; 
Nagase et al., 2002; Stepanovic et al., 2002), but they may 
colonize humans, and their isolation from various human 
clinical specimens have been reported (Couto et al., 2000; 
Marsou et al., 1999; Nagase et al., 2002). Moreover, Staph. 
sciuri has been associated with serious infections in human, 
such as endocarditis (Hedin and Widerstium, 1998), peritonitis 
(Wellet et al., 2000), septic shock (Horii et al., 2001), and 
wound infections (Stepanovic et al., 2002). Some investigators 
have reported the isolation of Staph. sciuri (Dromigny et al., 
2002) and Staph. lentus (Guirguitzova et al., 2002) from urine.  
Staph. saprophyticus was isolated from patients (1.7%) 
and not from healthy individuals. It was reported to act as 
primary pathogen causing urinary tract infections in young 
women (Baird. Parker, 1974; Arbuthnott, 1992; and Greo et al., 
1998) and possibly prostatitis and urethritis in men (Hovelius, 
1986).  
Staph. lugdunensis, originally isolated from human clinical 
specimens (Freney et al., 1988), was regarded as the etiological 
agent of 20 cases of left sided endocarditis (Cooper et al., 1998), 
and it was reported that this species accounted for 10% of all 
Staphylococcus species in human clinical specimen if Staph. 
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aureus and Staph. epidermidis strains are excluded (Herchline 
and Ayers, 1991).  
        Staph. gallinarium (one isolate) was originally isolated 
from poultry (Devriese et al., 1983) and it was isolated from 
human infection (Barrow & Felthman, 1993). No other report in 
which this species was isolated from human clinical specimens 
and in this study we did not obtain the report of clinical 
symptoms and patients personal history from hospital, so we 
could not judge whether this patient had been in contact with 
poultry and whether this species was a human pathogen or only 
contaminant or colonizing flora.  
         Staph. schleiferi was described in 1988 by Freney and co 
workers (Freney et al., 1988). It is commonly found living in 
carnivores, but may be transferred from pets to their owners or 
handlers (Kloos, 1997). Other studies suggested that this 
microorganism is a member of the human preaxillary skin flora 
(Da costa et al., 1998), but it is not known if thier carriage is 
persistent or transient. Since its first description, only a few data 
have been published in the literature on its pathogenicty. In 
studies of abscess formation in mice, Staph. schleiferi was 
shown to be more virulent than other coagulase-negative 
staphylococci species (Ferguson et al., 1991; Lambe et al., 
1990). It was implicated as the causative agent of several human 
infections (Celard et al., 1997; Da Costa et al., 1998; Leung et 
al., 1999), including a case of bacteremia with possible vertebral 
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infectious localization (Fleurette et al., 1989). The low 
occurence of Staph. schleiferi in human flora (Kloos, 1997) 
could explain the low frequency of infections due to this 
microorganism (one isolate in our study). However, it has been 
suggested that the real occurrence of these infections is 
underreported due to the erroneous identification of Staph. 
schleiferi as Staph. aureus in routine laboratory testing 
(Kluytman et al., 1998). Both strains are morphologically 
similar on blood agar. Moreover, Staph. schleiferi, like Staph. 
aureus, produces both clumping factor and thermonuclease.  
         Staph. chromogens ranked second (16.7%) and was 
isolated from patients only. This species was described as 
primary pathogen (Barrow and felthman, 1993). It was isolated 
by Huda (1997) from medical laboratories environment, by 
Hind (1997) from human ear, nose, abscess and urine. Devriese 
et al., (1978, 1985) isolated it from animal skin flora.  
         Huda (1997) found that Staph. aures, Staph. auricularis, 
Staph. gallinarum, Staph. lentus, Staph. schleiferi, Staph. 
lugdunensis could grow on Baird-Parker medium, whilst Staph. 
capitis-subsp-ureolyticus and Staph.chromogens failed to grow. 
In this study Staph. chromogens was primarly isolated on Baird-
Parker`s medium.  
       In this study we subjected 43 isolates from 14 different 
species of Staphylococcus isolates (Staph. gallinarum and 
 52
Staph. lugdunensis were not tested) to 9 different types of 
antibiotic including novobiocin (subjected to all isolates). 
Novobiocin used to identify Staphylococcus species. All isolates 
were sensitive to novobiocin, except Staph. sapophyticus, Staph. 
lentus, Staph. gallinarum, Staph. kloosii and Staph. sciuri. This 
novobiocin resistance was used by many authors as taxonomic 
character to separate them into groups of related species which 
can be further validated by molecular taxonomy (Kloos and 
Schleifer, 1997; Schleifer and Kloos, 1997, Schleifer et al., 
1997).  
       In this study all isolates showed either resistance or 
moderate sensitivity to penicillin and ampicillin except isolates 
of Staph. chromogens and Staph. caseolyticus which were found 
sensitive. This can be explained by the fact that penicillin and 
ampicillin were the most frequently used antibiotics in 
Khartoum State. Hence, bacteria are more likely to develop 
resistance against them. Actually, the medical authority inhibits 
the use of ampicillin for curing bacterial infections in the State 
due to the increased bacterial resistance. 
       In this study we found that Staphylococcus species isolated 
from healthy people were completely resistance to tetracycline. 
Although the finding was strange, but it was possible due to the 
fact that tetracycline is widely used in the Sudan in many 
applications, namely for topical treatment of wounds (as 
powder), as premedictation in poultry (prophylaxis), and as 
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injection for veterinary use (oxytetracycline). Nomads believed 
that this antibiotic can treat any disease and accordingly it is 
dramatically misused in the country. Lacy (1982, 1983) did not 
recommend the use of tetracycline in Staphylococcus 
pneumonia, septicemia, arthritis, wound infections and bone 
infections after surgery but in this cases he recommended 
cloxacillin and penicillin (oral).  
       The two species Staph. sciuri and Stph. lentus from group 
(1) and group (3) of patients were sensitive to streptomycin (the 
same pattern showed with cloxacillin) but in group (4). Staph. 
lentus was becoming resistance to both antibiotics.  
          Gentamicin was used in this study and it showed good 
results for the most of the isolates of Staphylococcus species 
from patients and healthy individuals. But due to its high 
toxicity, it should be used only when no other antibiotic was 
found suitable (Lacy, 1982, 1983).  
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CONCLUSION 
It was concluded from the present study that: 
• Various species of Staphylococcus other than Staph. aureus could 
be isolated from the nasal cavity of healthy and diseased people in 
Khartoum State. 
• Staph. aureus was the most frequently isolated species from the 
nasal cavity of healthy and diseased individuals. 
• Staphylococci isolated from patients acquired resistance gradually 
to different antibacterial agents as the residence time of patients 
increase in the hospital.   
• All Staphylococcus isolates were sensitive to gentamicin, 
chloramphincol, and coloxacillin.  
 
RECOMMENDATIONS 
Further studies are needed to clarify the role of staphylococci 
isolated from nasal cavity of patients in maintaining the antibacterial 
resistance in hospital environment and in the transfer of such resistance to 
other pathogenic bacteria.   
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